− monocytes are blood-circulating cells that play a role in inflammation and in the defense against pathogens. Here, we show that similar to natural killer (NK) cells, patrolling monocytes express high levels of S1PR5, a G-coupled receptor for sphingosine-1 phosphate. We found that S1pr5 −/− mice lack peripheral Ly6C − monocytes but have a normal number of these cells in the bone marrow (BM). Various lines of evidence exclude a direct contribution of S1PR5 in the survival of Ly6C − monocytes at the periphery. Rather, our data support a role for S1PR5 in the egress of Ly6C − monocytes from the BM. In particular, we observed a reduced frequency of patrolling monocytes in BM sinusoids of S1PR5 KO mice. Unexpectedly, S1P was not a chemoattractant for patrolling monocytes and had no significant effect on their viability in vitro. Moreover, the disruption of S1P gradients in vivo did not alter Ly6C − monocyte trafficking and viability. These data suggest that S1PR5 regulates the trafficking of monocytes via a mechanism independent of S1P gradients.
Introduction
Blood monocytes are bone marrow (BM) derived phagocytic cells that play an important role in innate immunity against different classes of pathogens [1] . Human and mouse monocytes have been subdivided into at least two subsets on the basis of expression of CD14 and CD16 (human) and Ly6C (mouse) and several functional, migratory [2] and transcriptomic [3] [4] [5] parameters.
Mouse Ly6C + monocytes are classical inflammatory monocytes, equivalent to human CD14 + CD16 − monocytes, as recently confirmed by gene profiling experiments [4, 5] . They are rapidly recruited to inflamed tissues in response to CC chemokine Receptor 2 (CCR2) [6] or CCR6 [7] ligands. During infection by various pathogens (intracellular bacteria, parasites, or viruses), they differentiate into TNF/iNOS producing dendritic cells (Tip-DCs) that produce large amounts of TNF-α, reactive oxygen species, and nitric oxide [8] . They can also differentiate into other types of DCs in other inflammatory contexts [9] . Moreover, Ly6C
+ monocytes are involved in atherosclerosis and can also differentiate into macrophages or myeloid suppressor cells [2] . The role of Ly6C − monocytes remains more elusive. Ly6C
− monocytes express high levels of CX 3 CR1, which allows them to patrol healthy tissues through long-range crawling on the surface of blood endothelium at the luminal side [10] , in response to membrane-anchored endothelial CX 3 CL1 [11] . This interaction is also required for their survival [11] . They express low levels of CCR2 and migrate less efficiently to inflamed tissues than inflammatory monocytes [12] . They have been proposed to be precursors of resident macrophage populations [13] . Moreover, their human equivalent, the CD16 + CD14 dim monocytes respond to virus infection through TLR7 and TLR8 (where TLR is Toll-like receptor) and produce TNF-α, IL-1β, and CC chemokine Ligand 3 (CCL3) [4] . A recent article also reported that Ly6C − monocytes were uniquely equipped with high levels of Fcγ receptors involved in antibodydependent cell cytotoxicity such as FcγR1 and FcγR4 [14] . Finally, they could also have a role in tissue repair and angiogenesis [13] . Monocytes are produced in the BM from macrophage-DC precursor [13] . Upon development, monocytes reach the blood circulation via BM sinusoids. Egress of Ly6C + monocytes from BM has been shown to be dependent on CCR2. This egress is weak under steady-state conditions but increases massively upon inflammation induced by bacterial infection [6] . During infections, low concentrations of TLR ligands in the bloodstream drive CCR2-dependent emigration of monocytes from the BM. BM mesenchymal stem cells and CXC chemokine ligand 12 abundant reticular cells rapidly express CCL2 in response to TLR ligands or bacterial infection and induce monocyte egress into the blood [15] . How Ly6C − monocytes reach the peripheral blood is however still unknown. Here, we report that Ly6C − monocytes expressed high levels of sphingosine-1 phosphate receptor 5 (S1PR5), previously involved in BM egress of natural killer (NK) cells [16] . S1pr5 −/− mice lack peripheral Ly6C − monocytes. Our data support a role for S1PR5
together with CCR2 in their egress from the BM. Modulation of extracellular S1P levels did not affect monocyte trafficking to the blood while it reduced T-cell egress from lymphoid organs, showing that S1P receptors regulate the trafficking of monocytes and lymphocytes using different mechanisms.
Results

S1PR5 is required for the presence of Ly6C
− monocytes in the periphery
We measured using quantitative RT-PCR the expression of all S1PR in different lymphocyte and monocyte populations sorted by flow cytometry from the BM. S1PR5 showed the highest expres- S1PR1 S1PR2 S1PR3 S1PR4 S1PR5 ND ND ND ND ND Relative to GAPDH Figure 1 . Expression of S1P receptors in different immune cell types. Ly6C + and Ly6C − monocytes, NK cells, and T cells were sorted by flow cytometry from the BM and their mRNA expression of S1P receptors was measured using semi quantitative RT-PCR, relative to GAPDH. Results are representative of two independent FACS sorting experiments and show the mean + SD of triplicate PCRs for each S1P receptor.
sion in monocyte subsets. S1PR5 was expressed 30 times higher in Ly6C
− monocytes than in Ly6C + monocytes (Fig. 1) . A similar difference in S1PR5 expression between monocyte subsets has been measured using microarrays by the Immgen consortium (http://www.immgen.org/databrowser/index.html) [17] . S1PR5 levels in Ly6C − monocytes were comparable to those in NK cells ( Fig. 1) , in which S1PR5 plays a role in BM egress [16] .
To investigate the function of S1PR5 in monocytes, we first compared the percentage of monocyte subsets in the blood of wild-type (WT) and S1pr5 −/− mice [18] by flow cytometry.
Results in Figure 2A -C showed a significant reduction of Ly6C − monocytes in the blood of S1pr5 −/− mice. This reduction was observed both in S1pr5 −/− female ( Fig. 2A and B) and male mice (Fig. 2C) . S1pr5 +/− heterozygous mice also showed a mild phenotype (Fig. 2B) . A strong reduction in the frequency of Ly6C − monocytes was also observed in the spleen, which is known to be an important reservoir for this subset [19] (Fig. 2D ), in the lymph nodes and in non-lymphoid organs such as the lung, liver, and kidney (Fig. 2E) . By contrast, the percentage of Ly6C − monocytes appeared normal in the BM of S1pr5 −/− mice (Fig. 2F) . Moreover, the percentage of Ly6C + monocytes was normal in all lymphoid organs of S1pr5 −/− mice tested (Fig. 2 , all panels).
To test if the role of S1PR5 in monocytes was cell-intrinsic, we generated mixed BM chimeras by reconstituting lethally irradiated mice with equal amounts of BM from WT (CD45.1 + ) and S1pr5
Six weeks after reconstitution, we measured CD45.1 and CD45.2 expression in different immune subsets in the blood and BM, and calculated the corresponding S1pr5 −/− to WT ratio for each subset. As previously reported [20] , for mature NK (mNK) cells, this ratio was very high in the BM and very low in the blood (Fig. 3, left panel) , reflecting the important role of S1PR5 in NK cell exit from the BM. For Ly6C + monocytes, the S1pr5 −/− to WT ratio was nearly 1 in both blood and BM ( 
subset. By contrast, for Ly6C
− monocytes, the S1pr5 −/− to WT ratio was near 0.5 in the BM and 0.1 in the blood (Fig. 3 , left panel). These data suggest that S1PR5 is important both for the development of Ly6C − monocytes and for their trafficking or their survival at the periphery.
S1PR5 and CCR2 but not CX 3 CR1 are essential for localization of Ly6C − monocytes to BM sinusoids
The paucity of patrolling monocytes in the periphery of S1pr5 −/− mice could be explained by a role of this receptor either in their egress from the BM or in their survival at the periphery. To try and discriminate between both hypotheses, we performed a series of experiments using Cx 3 Cr1 gfp/gfp and Ccr2 −/− mice as controls.
Indeed, CX 3 CR1 has been shown to regulate peripheral survival of patrolling monocytes but is devoid of chemotactic activity involved in BM egress. Reciprocally, CCR2 is essential for monocyte egress from the BM but is not involved in their survival. 16 h after transfer B e f o r e t r a n s f e r in the BM and a low frequency of these cells at the periphery (Fig. 4A) .
First, we compared the frequency of sinusoidal Ly6C − monocytes in the BM of WT, Cx 3 Cr1 gfp/gfp , Ccr2 −/− , and S1pr5 −/− mice using in vivo labeling of sinusoidal cells. This measurement has been shown to be proportional to the BM exit rate. Indeed, newly developed BM leukocytes transit from the BM parenchyma through the endothelium and into the BM sinusoids where they are transiently retained until their release into the blood circulation. Results presented in Fig. 4B showed that the percentage of sinusoidal Ly6C − monocytes was significantly decreased in the BM of S1pr5 −/− or Ccr2 −/− mice compared to the BM of WT mice. (Fig. 4C, right panel) . These data support a role for S1PR5 in the egress of Ly6C − monocytes rather than in their survival. Third, we compared the ex vivo viability of WT and S1pr5 −/− Ly6C − monocytes in the blood and BM of WT S1pr5 −/− chimeric mice using AnnexinV/7-AAD staining. In both compartments, the viability of S1pr5 −/− Ly6C − monocytes was slightly lower than that of WT Ly6C − monocytes (Fig. 4D) . Moreover, irrespective of the mouse genotype, the viability of Ly6C − monocytes was lower in the BM than in the blood. We also assessed viability of WT and S1pr5 −/− Ly6C − monocytes sorted by flow cytometry and cultured in the presence or absence of M-CSF. After 24 h, the viability of WT and S1pr5 −/− Ly6C − monocytes was similar in both culture conditions (Fig. 4E) (Fig. 4F) , as previously reported [21] . Altogether, this series of in vivo experiments demonstrate that CX 3 CR1 and S1PR5 regulate homeostasis of the peripheral pool of Ly6C − monocytes via different mechanisms. While CX 3 CR1 is clearly involved in their survival, S1PR5 is rather implicated in their egress from the BM although it may also contribute indirectly in their survival.
Modulation of S1P levels does not alter the trafficking and survival of Ly6C − monocytes
Finally, we investigated the role of S1P in the physiology of Ly6C In vitro, we measured responsiveness of monocytes to S1P gradients in chemotaxis chambers. No consistent migration of either population of monocytes was observed (Fig. 5A) , whereas both monocyte populations migrated in response to CCL2 gradients (Fig. 5B) . In the same experiments, NK cells migrated in response to both S1P and CCL2 gradients (Fig. 5A and B) , as previously reported [16] . WT and S1pr5 −/− Ly6C − monocytes migrated equally to CCL2 gradients, excluding a possible cross talk between CCR2 and S1PR5 (Fig. 5C ). We also cultured Ly6C − monocytes with S1P at concentrations similar to those observed in vivo. The addition of S1P at any concentration did not change monocyte viability in vitro (Fig. 5D and data not shown) . Next, we treated mice with the sphingosine lyase inhibitor deoxypyridoxine (DOP), which has been shown to dramatically increase S1P levels in tissues and disrupt S1P gradients in vivo [22] . Upon treatment with DOP, peripheral T-cell numbers dropped, as previously reported [22] . However, DOP had no effect on the trafficking or the number of Ly6C − monocytes (Fig. 5E ) and NK cells [22] even after prolonged (10 days) treatment (Fig. 5E) . The ex vivo viability of blood and BM Ly6C − monocytes was not modified either (Fig. 5F ). Altogether, these results suggest that S1P and S1P gradients are not involved in monocyte survival and unexpectedly not in their trafficking.
Discussion
In this article, we report for the first time a high expression of S1PR5 in patrolling monocytes and the paucity of these cells in the peripheral compartment of S1pr5 −/− mice. The following body of evidences supports a role for S1PR5 in BM egress of patrolling monocytes: (i) We previously showed that S1PR5 was involved in NK-cell egress from the BM to blood [20, 23] . Moreover, several other members of the family of S1P receptors (S1PR1, S1PR3) are clearly involved in egress of different leukocyte subsets from central and peripheral lymphoid organs [24] . (ii) Ly6C − monocytes are reduced in BM sinusoids of S1pr5 −/− mice, whereas they are preserved, or even slightly increased in Cx 3 cr1 gfp/gfp mice, which only exhibit impaired survival of Ly6C − monocytes at the periphery. (iii) The phenotype of S1pr5 −/− mice is very similar to that of Ccr2 −/− mice in which monocyte egress from the BM has been shown to be clearly impaired [15] . In particular, the number of Ly6C − monocytes was normal in the BM of S1pr5 −/− and Ccr2 do not survive either in the BM or in the blood after transfer. An intriguing observation is the absence of accumulation of S1pr5 −/− Ly6C − monocytes in the BM of S1pr5 −/− mice or WT S1pr5 −/− BM chimeric mice. A similar phenomenon (i.e. lack of accumulation of Ly6C − monocytes) was also observed in Ccr2 −/− mice and WT Ccr2 −/− BM chimeric mice. This suggests that the trafficking machinery of Ly6C − monocytes regulates somehow the developmental fitness of these cells and that an impairment of this machinery results in an impaired survival. As a matter of fact, we found that the ex vivo viability of Ly6C − monocytes in the BM was very low, confirming previous findings [25] . It is therefore possible that an impairment of their trafficking by means of CCR2 or S1PR5 deletion could further decrease the viability of these fragile cells.
In vivo modulation of S1P levels by pharmacological means did not alter homeostasis of Ly6C − monocytes (this report), while they dramatically reduced the number of T cells in circulation. These results show that S1P receptors operate through different modes of action in monocytes and in T cells. Several hypotheses could explain this paradox. First, the role of S1PR5 in Ly6C − monocytes could be S1P-independent. Other physiological ligands for this receptor have not yet been described but specific S1PR5 analogs binding with high affinity to this receptor have been synthesized [26] , and may therefore exist in vivo. Second, it has been reported that S1PR5 could act as a constitutively active receptor [27] like other G-protein-coupled receptors [28] . S1PR5 was in fact shown to decrease adenylyl cyclase and ERK activity in several cell lines in the absence of S1P, inducing cell rounding and detachment without promoting apoptosis [27] . This effect could contribute or even induce cell migration by preventing strong attachment to the stromal substrate of the BM. In this scenario, S1PR5 would not be a chemotactic receptor in monocytes, which would explain why we could not detect migration of these cells in response to S1P gradients in vitro. An alternative possibility could be that the form of S1P physiologically active in monocytes is different from the one we use in vitro. In fact, S1P can be found under different forms in vivo that could have differential activities on leukocyte subsets. Further studies are required to test these points. It remains also to be determined whether S1PR5 acts differently in monocytes and NK cells. Indeed, S1pr5 −/− mice lack both peripheral NK cells and Ly6C − monocytes but only NK cells accumulate in the BM of these mice and migrate in vitro in response to S1P. Altogether, our findings shed light on the long-sought mechanisms of exit of Ly6C − monocytes from the BM [12, 29] . They also show fundamental differences between both monocyte subsets, as the exit of Ly6C + monocytes from the BM relies only on pro-inflammatory signals mediated by CCR2 [6] whereas that of Ly6C − monocytes is primarily mediated by S1PR5. Furthermore, S1pr5 −/− mice constitute an interesting model to study the role of Ly6C − monocytes in immunity, a point that remains unclear.
Materials and methods
Mice and reagents
WT C57BL/6 mice were purchased from Charles River Laboratories (L'Arbresle, France). S1pr5 −/− mice [18] , Ccr2 −/− [30] , and Cx 3 cr1 gfp/gfp mice [31] have been previously described. In some experiments, we also used C57BL/6 CD45.1 mice or C57BL/6 CD45.1 × CD45.2 mice that were bred in our animal house. Female mice 8-24 week-old were used unless specified. DOP (Sigma, St. Louis, MO, USA) was provided in the drinking water (30 μg/mL) supplemented with glucose. Experimental procedures and mice housing were approved by the local Ethics Committee and carried out according to the French and European laws.
Generation of BM chimera
C57BL/6 CD45.1 × CD45.2 mice were irradiated twice at 450 rad within a 4-h interval. Four hours after the last irradiation, they received an intravenous injection of a 1:1 mixture of BM cells from WT CD45.1 and S1pr5 −/− CD45.2 mice. BM chimeras were analyzed 6-12 weeks after reconstitution.
In vivo labeling of sinusoidal lymphocytes
This technique was previously described [32] . Briefly, mice were injected intravenously with 1 μg anti-CD45 Mab (30F11) coupled to phycoerythrin (PE) or PE-cyanin-5 (BD Biosciences, San Jose, USA). Mice were sacrificed 2 min after antibody injection. BM was then collected and analyzed by flow cytometry.
Adoptive transfers
BM cells from WT CD45.1 and S1pr5
mice were prepared and mixed at a 1:1 ratio before intravenous injection (1 × 10 7 cells of each genotype in PBS) into anesthetized CD45.1 × CD45.2 C57BL/6 mice. Sixteen hours later, mice were sacrificed, blood and bone marrow was collected and the percentage of monocyte subsets of each donor mice was measured by flow cytometry after staining for CD45.1 and CD45.2 expression.
Cell viability
Cell viability was measured in ex vivo isolated cell suspensions using Annexin V and 7-AAD staining (BD Biosciences) and flow cytometry.
Antibodies and flow cytometry
BM, spleen, lung, lymph node, kidney, and blood cells were isolated and stained as previously described [33] . Cell counts were determined using an accuri C6 flow cytometer (BD Accuri Cytometers, Ann Arbor, MI, USA). Monocytes were identified as CD115 
Chemotaxis assays
For S1P migration assays, monocytes were purified from BM cells using a negative selection procedure. Briefly, freshly isolated BM cells were stained with purified antibodies against CD4, CD8, CD19, and Ly6G (eBioscience). Cells were then incubated with magnetic beads covered with goat anti-rat IgG (Qiagen, Hilden, Germany) before magnetic separation. After washing steps, cells were then suspended in RPMI1640 supplemented with 4 mg/mL fatty acid-free bovine albumin (Sigma). The same medium was used to prepare S1P (Sigma) at 10 −8 M or CCL2 at 50 ng/mL (R&D systems). Cell migration was measured in Transwell chambers (Costar, Cambridge, MA, USA) with 5-μm pore-width polycarbonate filters. After 2 h, transmigrated cells were stained for CD3, NK1.1, CD27 and CD11b or CD11b, Ly6G and Ly6C and counted by flow cytometry as described previously [16] .
Quantitative RT-PCR
Lymphocyte or monocyte subsets stained with the appropriate antibodies were sorted using a FACS Aria cell sorter (Becton Dickinson). RNA was extracted with the RNeasy micro kit (Qiagen), which includes treatment with DNase I. We used Superscript II reverse transcriptase (Invitrogen, Carlsbad, CA, USA) to generate cDNA for RT-PCR. PCR was carried out with a SybrGreenbased kit (FastStart Universal SYBR Green Master, Roche, Basel, Switzerland) on a StepOne plus instrument (Applied biosystems, Carlsbad, CA, USA). Primers were designed using the oligoperfect software (Invitrogen, Carlsbad, CA, USA). The following primers were used: S1pr1 (F: AAATGCCCCAACGGAGACTCTG, R: TTGCTGCGGCTAAATTCCATGC), S1pr2 (F: CCCAACTCCGGGA-CATAGA, R: ACAGCCAGTGGTTGGTTTTG), S1pr3 (F: TCAGTG-GTTCATCATGCTGG, R: CAGGTCTTCCTTGACCTTCG), S1pr4 (F: AAGACCAGCCGTGTGTATGG, R: TCAGCACGGTGTTGAGTAGC), S1pr5 (F: GCCTGGTGCCTACTGCTACAG, R: CCTCCGTCGCTG-GCTATTTCC), Gapdh (F: GCATGGCCTTCCGTGTTC, R: TGTCAT-CATACTTGGCAGGTTTCT). S1PR expression level in the different cell subsets was normalized to GAPDH expression levels.
In vitro culture of Ly6C − monocytes Ly6C − monocytes were sorted by flow cytometry using a FACS Aria cell sorter (Becton Dickinson). They were cultured in flat bottom 96 well plates (25000/condition) in duplicates. For cultures with M-CSF, the culture medium was supplemented with 10% FCS in the presence or absence of 5% of an M-CSF-containing cell culture supernatant. In some experiments, cells were resuspended in medium supplemented with 4 mg/mL fatty acid-free bovine albumin (Sigma). The same medium was used to prepare S1P (Sigma), which was added or not to the cultures at a concentration of 10 −6 M.
Statistical analyses
Statistical analyses were performed using two-tailed t-tests or nonparametric tests when appropriate. These tests were run on the Prism software (GraphPad, La Jolla, CA, USA). Levels of significance are expressed as p-values (*p < 0.05, **p < 0.01, ***p < 0.001).
